newsfilter
← Latest News
GlobeNewswire·

Sigilon Therapeutics Appoints Brooke Story, M.B.A., to its Board of Directors

CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced the